Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for combination therapy for preventing or treating cancer containing tumor-specific drug conjugate and anti-PD-L1 antibody as active ingredients

Pharmaceutical composition for combination therapy for preventing or treating cancer containing tumor-specific drug conjugate and anti-PD-L1 antibody as active ingredients

US Patent 11498946 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compounds for red blood cell-mediated delivery of an active pharmace2024
Therapeutic compounds for red blood cell-mediated delivery of an active pharmace2024
Visible light-activatable nanoparticles for cancer immunotherapy and use thereof2023
Visible light-activatable nanoparticles for cancer immunotherapy and use thereof2023
Probe for measuring activity of Caspase-1 and composition for diagnosis of infla2023
Immunoregulatory protein-siRNA complex having anticancer activity2022
Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite2021
Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite2021
Nanocage and use thereof2021
Tumor cell-specific responsive self-assembling drug nanoconjugate2020
Glycopeptide for contrast agent targeting cancer cells and contrast agent kit co2019
Glycopeptide for contrast agent targeting cancer cells and contrast agent kit co2019